
Orlistat Capsule
Form: Capsules
Strength: 120 mg; Alli(60 mg)
Reference Brands: Xenical(US & EU)
Category: Weight Loss drugs
Orlistat capsules, marketed as Xenical (prescription) and Alli (OTC), are approved in the US by the FDA and in the EU via EMA for weight management and obesity. Regulatory approval requires dossiers including safety assessments, clinical efficacy, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for effective approval, while the EMA ensures compliance with regional safety and manufacturing regulations. For dossier preparation, regulatory pathways, and market access guidance, visit PharmaTradz. Proper regional adherence supports timely approval, safe use, and global availability, helping consumers worldwide achieve weight loss through effective dietary fat-blocking therapy supported by regional regulations.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Metreleptin Injectable Solution
Strength: 11.3 mg/vial
Form: Injectable Solution
Reference Brands: Myalept(US & EU)
View Details Get Enquirysetmelanotide Injectable solution
Strength: 4 mg/mL
Form: Injectable Solution
Reference Brands: Imcivree(Us & EU)
View Details Get Enquirynaltrexone hydrochloride + bupropion hydrochloride ER tablets
Strength: 8 mg naltrexone hydrochloride / 90 mg bupropion hydrochloride
Form: ER tablets
Reference Brands: Contrave(US & EU)
View Details Get EnquiryPhentermine/Topiramate Extended-Release Capsules
Strength: 3.75 mg/23 mg, 7.5 mg/46 mg, and 15 mg/92 mg
Form: Capsules
Reference Brands: Qsymia(US & EU)
View Details Get Enquiry